Platinum Research Network Nominated for “Best Clinical Trial Network” at World Vaccine Congress

Share Article

Nominated for VIE (Vaccine Industry Excellence) Award in the category of “Best Clinical Trial Network”.

The world's most exciting vaccine event involves R&D and Strategic Partnering for the Global Vaccine Industry. Following voting across the industry, Platinum Research Network (PRN) made the finalist list.

PRN is a yearly sponsor and exhibitor at World Vaccine Congress in DC. In 2020, attendance was planned by over 22 teammates across the research network, some of whom had speaking engagements covering the hottest topics in clinical research.

Vice President of Platinum Research Network, Jason Roth, states, “We were eager to reconnect with our colleagues at World Vaccine Congress in DC this year. We support the decision to postpone the meeting to help prevent the spread of Coronavirus. We look forward to attending the rescheduled meeting in late September. Little did we know upon cancellation, so many members in our network would be on the forefront of groundbreaking research involving SARS-COV-2 and COVID-19.”

*Vaccine Industry Excellence (VIE) awards have been created to honour and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry.

Twelve categories will be hotly contested in 2020. Platinum Research Network is proud to be selected as one of the world leaders in vaccine research providing quality data among its peers.

*https://www.terrapinn.com/Conference/world-vaccine-congress-washington/index.stm

Jason Roth, VP Business Development at Platinum Research Network is available for interview via video, phone or any other platform at this time.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jason Roth
Visit website